Maternal insulin sensitivity linked to fetal brain activity

April 4, 2014
Maternal insulin sensitivity linked to fetal brain activity

(HealthDay)—Maternal insulin sensitivity is associated with fetal brain responses, according to a study published in the online March 25 in Diabetologia.

Katarzyna Linder, from the University Hospital Tübingen in Germany, and colleagues examined whether maternal metabolic changes during the oral glucose tolerance test influence activity in a study of 13 healthy pregnant women. Glucose and insulin measurements were taken at 0, 60, and 120 minutes to assess . Fetal auditory evoked fields were recorded at each time point and response latencies were determined.

The researchers observed an increase in mean maternal insulin from a fasting level of 67 ± 25 to 918 ± 492 pmol/l at 60 minutes after ingestion of glucose. Glucose levels increased from 4.4 ± 0.3 to 7.4 ± 1.1 mmol/l. Fetal response latencies decreased over the same period, from 297 ± 99 to 235 ± 84 ms (P = 0.01), and were stable until 120 minutes (251 ± 91 ms; P = 0.39). Sixty minutes after ingestion, a negative correlation was seen between maternal insulin sensitivity and fetal response latencies (P = 0.02). On categorization of the group according to maternal insulin sensitivity, a slower response to auditory stimuli was seen for fetuses of insulin-resistant mothers (283 ± 79 ms) compared with insulin-sensitive mothers (178 ± 46 ms; P = 0.03).

"These findings provide the first evidence of a direct effect of maternal metabolism on fetal brain activity and suggest that central may be programmed during ," the authors write.

Explore further: Response of unborn children to glucose associated with mother's insulin sensitivity

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Response of unborn children to glucose associated with mother's insulin sensitivity

March 25, 2014
A study published in Diabetologia (the journal of the European Association for the Study of Diabetes) is the first to provide direct evidence that fetal brain response to a dose of sugar given orally to its mother is associated ...

Sucralose affects response to oral glucose load in obese

July 2, 2013
(HealthDay)—For obese adults who do not use non-nutritive sweetener (NNS), sucralose affects the glycemic and insulin responses to an oral glucose load, according to a study published online April 30 in Diabetes Care.

Cause for exaggerated insulin response in subset of bariatric surgery patients identified

March 27, 2014
University of Cincinnati (UC) researchers have discovered that altered islet cell function and reduced insulin clearance contribute to excessive post-meal insulin response in patients experiencing low blood sugar symptoms ...

Artificial sweeteners produce no glucagon response

January 14, 2014
(HealthDay)—Artificial sweeteners do not produce any changes in glucose metabolism compared to a glass of water, according to a letter published in the December issue of Diabetes Care.

Maternal glycemic status linked to epigenetic changes

March 9, 2012
(HealthDay) -- Maternal glycemic status and adiponectin levels are linked to epigenetic changes in the adiponectin gene (ADIPOQ), according to a study published online March 6 in Diabetes.

Model predicts blood glucose levels 30 minutes later

March 25, 2014
A mathematical model created by Penn State researchers can predict with more than 90 percent accuracy the blood glucose levels of individuals with type 1 diabetes up to 30 minutes in advance of imminent changes in their levels—plenty ...

Recommended for you

Thirty-year study shows women who breastfeed for six months or more reduce their diabetes risk

January 16, 2018
In a long-term national study, breastfeeding for six months or longer cuts the risk of developing type 2 diabetes nearly in half for women throughout their childbearing years, according to new Kaiser Permanente research published ...

Diabetes gene found that causes low and high blood sugar levels in the same family

January 15, 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

Discovery could lead to new therapies for diabetics

January 12, 2018
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy ...

Enzyme shown to regulate inflammation and metabolism in fat tissue

January 11, 2018
The human body has two primary kinds of fat—white fat, which stores excess calories and is associated with obesity, and brown fat, which burns calories in order to produce heat and has garnered interest as a potential means ...

Big strides made in diabetes care

January 5, 2018
(HealthDay)—This past year was a busy, productive one for diabetes research and care.

Gene therapy restores normal blood glucose levels in mice with type 1 diabetes

January 4, 2018
Type 1 diabetes is a chronic disease in which the immune system attacks and destroys insulin-producing beta cells in the pancreas, resulting in high blood levels of glucose. A study published January 4th in Cell Stem Cell ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.